Fundraising FoxPotenza Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into Potenza Therapeutics
Sign up to see every warm intro you have to Potenza Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Potenza Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CS
Cynthia Seidel-DuganExecutive
DC
David CordoExecutive
DH
Daniel HicklinExecutiveManaging Partner at MPM Capital
RL
Reid LeonardChief Operating Officer2018–2018Dr. Reid Leonard is Chief Operating Officer of Potenza Therapeutics, an immune-oncology company that he co-founded in 2014 and led through business development and corporate strategy roles before its acquisition by Astellas Pharma. Previously, he spent 25 years at Merck & Co. in drug discovery and business development focused on ion channels and GPCR signaling, and holds a Ph.D. in neuroscience from Purdue University and a B.A. from Brandeis University.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$35M disclosed across 2 rounds · 2014–2017
▶$5MraisedDec 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$5MraisedDec 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shunichiro MatsumotoDirector
- Luke EvninDirector
- Cynthia Seidel-DuganExecutive Officer
- Reid LeonardExecutive Officer
- Daniel HicklinExecutive Officer, Director
- Arnold OronskyDirector
- David CordoExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$30MraisedMar 2016 · 6 investors · PharmaceuticalsRule 506(b)
▶$30MraisedMar 2016 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cynthia Seidel-DuganExecutive Officer
- David CordoExecutive Officer
- Daniel HicklinExecutive Officer, Director
- Arnold OronskyDirector
- Reid LeonardExecutive Officer
- Luke EvninDirector
- Sakae AsanumaDirector
- Offering amount
- $38M
- Amount sold
- $30M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Potenza Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Potenza Therapeutics's investors?
- Potenza Therapeutics's investors include MPM BioImpact.
- How much funding has Potenza Therapeutics raised?
- Potenza Therapeutics has disclosed $35M raised across 2 rounds.
- Where is Potenza Therapeutics headquartered?
- Potenza Therapeutics is headquartered in Cambridge, US.